[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR088950A1 - Proceso para la preparacion de drospirenona - Google Patents

Proceso para la preparacion de drospirenona

Info

Publication number
AR088950A1
AR088950A1 ARP120104389A ARP120104389A AR088950A1 AR 088950 A1 AR088950 A1 AR 088950A1 AR P120104389 A ARP120104389 A AR P120104389A AR P120104389 A ARP120104389 A AR P120104389A AR 088950 A1 AR088950 A1 AR 088950A1
Authority
AR
Argentina
Prior art keywords
drospirenone
mixture
androstan
dimethylene
preparation process
Prior art date
Application number
ARP120104389A
Other languages
English (en)
Inventor
Lenna Roberto
Andrea Vanossi
Original Assignee
Ind Chimica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11190133.6A external-priority patent/EP2597101A1/en
Priority claimed from IT000146A external-priority patent/ITMI20120146A1/it
Application filed by Ind Chimica Srl filed Critical Ind Chimica Srl
Publication of AR088950A1 publication Critical patent/AR088950A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Proceso para la preparación de drospirenona que comprende los siguientes pasos: a) oxidación del compuesto 17a-(3-hidroxipropil)-6b,7b;15b,16b-dimetilen-5b-androstan-3b,5,17b-triol con un agente oxidante en presencia de cantidades catalíticas de radical 2,2,6,6-tetrametilpiperidina-1-oxil o un derivado suyo; b) extracción por destilación del solvente de la mezcla de reacción, con obtención de un producto oleoso en bruto que contiene 6b,7b;15b,16b-dimetileno-5b-hidroxi-3-oxo-17a-androstan-21,17-carbolatón; c) agregado a dicho producto oleoso en bruto de una mezcla de agua y una base orgánica y calentamiento de la mezcla obtenida de este modo a una temperatura comprendida entre 45 y 90ºC, para formar drospirenona.
ARP120104389A 2011-11-22 2012-11-22 Proceso para la preparacion de drospirenona AR088950A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161562626P 2011-11-22 2011-11-22
EP11190133.6A EP2597101A1 (en) 2011-11-22 2011-11-22 Process for the preparation of drospirenone
IT000146A ITMI20120146A1 (it) 2012-02-03 2012-02-03 Processo per la preparazione di composti policiclici insaturi dotati di attivita' farmacologica

Publications (1)

Publication Number Publication Date
AR088950A1 true AR088950A1 (es) 2014-07-16

Family

ID=48469153

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104389A AR088950A1 (es) 2011-11-22 2012-11-22 Proceso para la preparacion de drospirenona

Country Status (8)

Country Link
US (1) US9394334B2 (es)
EP (1) EP2782924B1 (es)
AR (1) AR088950A1 (es)
CA (1) CA2856324C (es)
ES (1) ES2607778T3 (es)
PL (1) PL2782924T3 (es)
UY (1) UY34464A (es)
WO (1) WO2013076118A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0075189B1 (en) 1981-09-21 1985-08-28 Schering Aktiengesellschaft 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
US8334375B2 (en) 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone

Also Published As

Publication number Publication date
CA2856324C (en) 2019-08-13
UY34464A (es) 2013-05-31
WO2013076118A1 (en) 2013-05-30
PL2782924T3 (pl) 2017-07-31
CA2856324A1 (en) 2013-05-30
US20140343275A1 (en) 2014-11-20
US9394334B2 (en) 2016-07-19
EP2782924A1 (en) 2014-10-01
ES2607778T3 (es) 2017-04-04
EP2782924B1 (en) 2016-09-21

Similar Documents

Publication Publication Date Title
DOP2018000273A (es) Compuestos químicos
MX363512B (es) Proceso de glicoconjugacion.
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
BR112015019432A2 (pt) Compostos de tubulisina, métodos de produção e uso
BR112012000968A8 (pt) Composto, composição e método para inibir uma fosfatidil inositol-3 cinase.
DOP2010000267A (es) Compuesto heterociclico
SV2010003673A (es) Compuestos heterociclicos novedosos y usos de los mismos
AR091604A1 (es) Potenciacion de autofagia o aumento de longevidad por administracion de urolitinas o precursores de las mismas, compuesto
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CY1113449T1 (el) Αντι-ιικες συνθεσεις που περιλαμβανουν γερανιολη και καρβονη
AR088983A1 (es) Procedimiento para la preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
AR088564A1 (es) PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3
NI201400042A (es) 2 - tiopirimidinonas
UY32704A (es) Compuestos de 2,3-dihidro-1h-indeno
BR112015030724A2 (pt) processo de polimerização na presença de uma composição com ação antiestática
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2016000007A (es) Pirazolpiridinas sustituidas
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
CU24499B1 (es) Proceso para preparar ésteres de ácido láctico y ácido 2-hidroxi-3-butenoico a partir de azúcares
BR112013031103A2 (pt) síntese de derivados de 7-acetileno quinonametídeo e sua aplicação como retardadores da polimerização de vinilícos
AR086647A1 (es) Metodos para tratar el mesotelioma con un compuesto inhibidor de la pi3k
BR112015029714A2 (pt) processo para preparar derivados de 4,6-bis(ariloxi)pirimidina
AR107494A1 (es) Proceso para la preparación de osimertinib (azd9291) o una sal del mismo, y “azd9291 anilina” o una sal de la misma
AR101136A1 (es) Proceso para la preparación de ácidos 3-hidroxipicolínicos

Legal Events

Date Code Title Description
FG Grant, registration